• 1

    Seim A, Dreyer G, Addis D, 1999. Controlling morbidity and interrupting transmission: twin pillars of lymphatic filariasis elimination. Rev Soc Bras Med Trop 32 :325–328.

    • Search Google Scholar
    • Export Citation
  • 2

    Fan PC, Peng HW, Chen CC, 1995. Follow-up investigations on clinical manifestations after filariasis eradication by diethylcarbamazine medicated common salt on Kihmen (Quemoy) Island, Republic of China. Am J Trop Med Hyg 98 :461–464.

    • Search Google Scholar
    • Export Citation
  • 3

    Suma TK, Shenoy RK, Kumaraswami V, 2002. Efficacy and sustainability of a footcare programme in preventing acute attacks of adenolymphangitis in Brugian filariasis. Trop Med Int Health 7 :763–766.

    • Search Google Scholar
    • Export Citation
  • 4

    Shenoy RK, Suma TK, Rajan K, Kumaraswami V, 1998. Prevention of acute adenolymphangitis in Brugian filariasis: comparison of the efficacy of ivermectin and diethylcarbamazine, each combined with local treatment of the affected limb. Ann Trop Med Parasitol 92 :587–594.

    • Search Google Scholar
    • Export Citation
  • 5

    McPherson T, 2003. Impact on the quality of life of lymphoedema patients following introduction of a hygiene and skin care regimen in a Guyanese community endemic for lymphatic filariasis: a preliminary clinical intervention study. Filaria J 2 :1.

    • Search Google Scholar
    • Export Citation
  • 6

    Coreil J, Mayard G, Addis D, 2002. Benefits of support groups in the management of filariasis. TDR Final Report Series, No. 56, Lymphatic Filariasis. Geneva: World Health Organization.

  • 7

    Dreyer G, Addiss D, Noroes J, 2002. Basic Lympheodema Management: Treatment and Prevention of Problems Associated with Lymphatic Filariasis. Hollis, NH: Hollis Publishing Co.

  • 8

    Molyneux DH, Zagaria N, 2002. Lymphatic filariasis elimination: progress in global programme development. Ann Trop Med Parasitol 96 (Suppl 2):S15–S40.

    • Search Google Scholar
    • Export Citation
  • 9

    Vaqas B, Ryan TJ, 2003. Lymphedema: pathophysiology and management in resource-poor settings—relevance for lymphatic filariasis control programmes. Filarial J 2 :4.

    • Search Google Scholar
    • Export Citation
  • 10

    El Setouhy M, Ramzy RMR, Ahmed ES, Kandil AM, Hussain O, Farid HA, Helmy H, Weil GJ, 2003. A randomized clinical trial comparing single and multi-dose combination therapy with diethylcarbamazine and albendazole for treatment of Bancroftian filariasis. Am J Trop Med Hyg 70 :191–196.

    • Search Google Scholar
    • Export Citation
  • 11

    Dreyer G, Pires ML, Andrade LD, Lopes E, Medeiros Z, Tenorio J, Coutinho A, Noroes J, Figueredo-Silva J, 1994. Tolerance of diethylcarbamazine by microfilaraemic and amicrofilaraemic individuals in an endemic area of bancroftian filariasis, Recife, Brazil. Trans R Soc Trop Med Hyg 88 :232–236.

    • Search Google Scholar
    • Export Citation
  • 12

    Dreyer G, Addiss D, Noroes J, Amaral F, Rocha A, Coutinho A, 1996. Direct assessment of the adulticidal efficacy of repeat high-dose ivermectin in Bancroftian Filariasis. Trop Med Int Health 1 :427–432.

    • Search Google Scholar
    • Export Citation
  • 13

    Bockarie MJ, Tisch DJ, Kastens W, Alexander ND, Dimber Z, Bockarie F, Ibam E, Alpers MP, Kazura JW, 2002. Mass treatment to eliminate filariasis in Papua New Guinea, N Engl J Med 347 :1841–1848.

    • Search Google Scholar
    • Export Citation
  • 14

    Dreyer G, Noroes J, Figueredo-Silva J, Piessens, WF, 2002. Pathogenesis of lymphatic disease in bancroftian filariasis: a clinical perspective. Parasitol Today 16 :544–548.

    • Search Google Scholar
    • Export Citation
  • 15

    Dreyer G, Medeiros Z, Netto MJ, Leal NC, de Castro LG, Piessens WF, 1999. Acute attacks in the extremities of persons living in an area endemic for bancroftian filariasis: differentiation of two syndromes. Trans R Soc Trop Med Hyg 93 :413–417.

    • Search Google Scholar
    • Export Citation
  • 16

    Taylor MJ, 2003. Wolbachia in the inflammatory pathogenesis of human filariasis. Ann N Y Acad Sci 990 :444–449.

 
 
 

 

 
 
 

 

 

 

 

 

 

2.3 LF DISEASE—CLINICAL MANAGEMENT

View More View Less
Save